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Abstract
Background: The microbial populations of the human intestinal tract and their relationship to specific diseases
have been extensively studied during the last decade. However, the characterization of the human bile microbiota as a
whole has been hampered by difficulties in accessing biological samples and the lack of adequate methodologies to
assess molecular studies. Although a few reports have described the biliary microbiota in some hepatobiliary diseases,
the bile microbiota of healthy individuals has not been described. With this in mind, the goal of the present study was
to generate fundamental knowledge on the composition and activity of the human bile microbiota, as well as
establishing its potential relationship with human bile-related disorders.
Results: Human bile samples from the gallbladder of individuals from a control group, without any record of
hepatobiliary disorder, were obtained from liver donors during liver transplantation surgery. A bile DNA extraction
method was optimized together with a quantitative PCR (qPCR) assay for determining the bacterial load. This allows
the selection of samples to perform functional metagenomic analysis. Bile samples from the gallbladder of individuals
suffering from lithiasis were collected during gallbladder resection and the microbial profiles assessed, using a 16S
rRNA gene-based sequencing analysis, and compared with those of the control group. Additionally, the metabolic
profile of the samples was analyzed by nuclear magnetic resonance (NMR). We detected, for the first time, bacterial
communities in gallbladder samples of individuals without any hepatobiliary pathology. In the biliary microecosystem,
the main bacterial phyla were represented by Firmicutes, Bacteroidetes, Actinobacteria, and Proteobacteria. Significant
differences in the relative abundance of different taxa of both groups were found. Sequences belonging to the family
Propionibacteriaceae were more abundant in bile samples from control subjects; meanwhile, in patients with
cholelithiasis members of the families Bacteroidaceae, Prevotellaceae, Porphyromonadaceae, and Veillonellaceae were
more frequently detected. Furthermore, the metabolomics analysis showed that the two study groups have different
metabolic profiles.
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Conclusions: Our results indicate that the gallbladder of human individuals, without diagnosed hepatobiliary
pathology, harbors a microbial ecosystem that is described for the first time in this study. Its bacterial representatives
and metabolites are different from those detected in people suffering from cholelithiasis. In this regard, since liver
donors have been subjected to the specific conditions of the hospital’s intensive care unit, including an antibiotic
treatment, we must be cautious in stating that their bile samples contain a physiologically normal biliary microbiome.
In any case, our results open up new possibilities to discover bacterial functions in a microbial ecosystem that has not
previously been explored.
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Background
Bile is a biological fluid, mainly constituted by bile acids
(BA), cholesterol, phospholipids, and proteins. Bile is syn-
thesized in the liver and stored in the gallbladder. Its main
physiological function is to facilitate fat absorption in the
small intestine during digestion [1]. Several bile-related
disorders can modify bile functionality, but the most fre-
quent is the generation of gallstones, either in the gallblad-
der or in the bile duct, the so-called cholelithiasis, with a
prevalence among adults normally above 10% [2]. Gall-
stone formation is attributed to a combination of environ-
mental and genetic causes, typically linked to cholesterol
supersaturation. The primary constituent of gallbladder
stones is cholesterol, whereas calcium bilirubinate pre-
dominates in pigmented bile duct stones. To date, chole-
cystectomy remains the most effective treatment option
for chronic carriers with gallbladder lithiasis [3].
The landscape of microorganisms inhabiting our gastro-
intestinal tract has been extensively studied during the last
few years [4–6]. Furthermore, we currently know that some
biological fluids in different locations in our body also have
an autochthonous microbiota that suffers alterations de-
pending on the physiological state of the host [7, 8]. How-
ever, very little is known about the microbial inhabitants of
human bile. Current knowledge is mainly limited to a few
species of cultivable bacteria that have been associated with
physiological disorders such as cholelithiasis. In this regard,
our understanding of the exact contribution of bacteria in
gallstone formation is very limited, although a possible as-
sociation between bacteria and the etiology of gallstones
has been suggested and enterobacteria are frequently iso-
lated from bile aspirates or gallbladder bile from cholelithia-
sis patients [9–12]. Only very recently, a few authors have
analyzed, using culture-independent techniques, the micro-
biota of the biliary tract and the gallbladder and its associ-
ation with bile-related diseases. In these studies, it was
shown that Enterobacteriaceae members are abundant mi-
croorganisms in the biliary tract of acute cholecystitis and
gallstone patients [13, 14]. It was also observed that oral
cavity and respiratory tract microorganisms were more
prevalent than intestinal microorganisms in the microbiota
of the common bile duct of gallstone disease patients [15]
or that the genera Prevotella, Streptococcus, Veillonella,
Fusobacterium, and Haemophilus are prevalent in the bile
microbial communities of the bile duct of primary
sclerosing cholangitis patients [16], among other findings
[13, 17, 18]. All these works demonstrated that a microbial
community is present in the human gallbladder and the bile
duct in some hepatobiliary disorders. Nevertheless, the
human bile microbiota in individuals without any bile or
liver-related disorder had not been explored until now.
In a previous work, we characterized the gallbladder
microbiota of healthy pigs [19]. This fact, together with
our experience in bacterial bile resistance mechanisms,
led us to believe that the human gallbladder may contain
an autochthonous microbiota, and the ability of resident
bacteria to live in, survive, and colonize bile must neces-
sarily reflect a specific bacterial physiology, well adapted
to face the environmental challenges found in such a
specific niche, and thus different from the rest of the mi-
croorganisms inhabiting other gastrointestinal habitats.
Thus, we performed the first study focused on the
characterization of human gallbladder microbiota in a
group of individuals free from hepatobiliary diseases
(control group) vs a group with diagnosed cholelithiasis
(non-lithiasis vs lithiasis), with the aim of generating
new knowledge about bile microbial profiles, functions,
and activities and to contribute to complete our under-
standing of the complex landscape of different microbio-
tas in the human body (Table 1).
Results
Bacterial load in bile samples
In order to perform further molecular analyses, we firstly
optimized a method for DNA extraction and quantifica-
tion from human bile. For this purpose, bile samples
from liver donors that did not meet the inclusion criteria
for investigating the microbiome (see the “Methods”
section for details) were used to extract biliary DNA fol-
lowing a phenol-based protocol. A quantitative PCR
(qPCR) assay was developed to determine the bacterial
load. General primer pairs, targeting the 16S rRNA gene
of prokaryotic microorganisms and the18S rRNA gene
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of eukaryotic cells, were used. DNA quantification and
recovery after artificial enrichment of these bile samples
with different amounts of bacterial cells was performed.
Total DNA was extracted and used as a template for
qPCR validation experiments, and the threshold cycle
(Ct) values were used to calculate the efficiency and the
limit of quantification. Dilution series of eukaryotic and
prokaryotic DNA, obtained from cell cultures of Lacto-
coccus lactis NZ9000 and HT29 cells, allowed us to per-
form a linear regression analysis based on the Ct data,
yielding a high coefficient of determination (R2 > 0.99).
The lowest concentration of the standard was close to
the Ct value of the non-template control, so 102 bacter-
ial cells/ml was established as the limit of detection of
our assay. Afterwards, DNA samples obtained from the
bile of a group of 13 liver donors (see the “Methods”
section for general characteristic of the selected control
group of donors) were analyzed with the qPCR assay
and the bacterial load and the ratio of prokaryotic DNA
with respect to eukaryotic DNA established. We ob-
served that bacterial cell counts between individuals did
not vary substantially (Fig. 1). The proportion of
eukaryotic DNA was superior by at least tenfold com-
pared to prokaryotic DNA in all cases.
Overall, the qPCR assay was useful to determine the
levels of total bacteria in bile and allowed us to select
samples for performing shotgun sequencing.
Functional metagenomic analysis of bile samples
Three bile samples (encoded in this study as H-04, H-
05, and H-06) were selected based on the results ob-
tained by qPCR (16S rRNA gene/18S rRNA gene ratio ≤
0.01) and DNA concentration and quality (≥ 15 ng/μl
and a ratio 260/280 ≥ 1.6). The metagenomic analysis
performed by shotgun sequencing resulted in a mean of
2,556,103 raw sequences per sample obtained, of which
a total of 7,169,256 proved to be of high quality consid-
ering the three samples together. After the removal of
human DNA, the numbers of final reads were 1,963,038
for H-04, 342,649 for H-05, and 80,384 for H-06. These
sets of sequences served as input for further analyses.
Taxonomy assignment based on coding reads against
non-redundant NCBI database with BLASTx and the
metagenome analyzer MEGAN5 revealed that most of
the quality-filtered reads resulted from bacteria, al-
though the presence of archaea, virus, and other
eukaryotic microorganisms was also noticed (Table 2).
Within the bacteria domain, four main phyla, Firmicutes,
Table 1 Demographic and clinical features of cholelithiasis patients
Subject Age (years) Sex Clinical history Altered parameters in blood test
(with higher levels than those
considered normal)a
C-01 73 F Non-cirrhotic portal hypertension.
Alteration of liver function due to
chemotherapy.
Digestive hemorrhage (2 years
before collecting the bile sample)
ALP, AST, and GGT
C-02 67 M Hemicolectomy (3 years before
collecting the bile sample)
GGT, TB, DB, and TG
C-03 60 F Hypercholesterolemia –
C-04 58 F – AST and GGT
C-05 67 M – DB and TB
C-06 55 F Obesity type II (BMI 38.5) ALT, AST, Glu, GGT, and TC
C-07 27 F – –
C-08 50 M Obesity type I (BMI 32.2)
Acute lithiasic pancreatitis (7 months
before collecting the bile sample)
GGT, LDL, TC, and TG
C-09 38 F – LDL and TC
C-10 33 F – –
C-11 36 F Obesity type II (BMI 36.1) ALT and GGT
C-12 44 F – TG
C-13 50 F – ALT and AST
C-14 70 F – DB, GGT, and TB
– no relevant information, BMI body mass index, ALP alkaline phosphatase, ALT alanine aminotransferase, AST aspartate aminotransferase, DB direct bilirubin,
GGT gamma-glutamyl transferase, Glu glucose, LDL cholesterol LDL, TB total bilirubin, TC total cholesterol, TG triglycerides, F female, M male
aAt the time of sampling
Molinero et al. Microbiome           (2019) 7:100 Page 3 of 17
Bacteroidetes, Actinobacteria, and Proteobacteria, pre-
dominate in the bile microbiome. Other phyla, such as
Verrucomicrobia, Chlamydiae, Acidobacteria, Plancto-
mycetes, Cyanobacteria, Spirochaetes, and Fusobacteria,
were noticed in the three samples at low percentages
(mean between 0.05 and 0.5%) after normalization
against the total number of sequences assigned to
bacteria.
When performing the gene annotation and functional
classification of the metagenomes obtained for the three
samples, assignation results for the main functional cat-
egories of COG (Clusters of Orthologous Groups) were
closely related. The COG functional classes, as observed
in Fig. 2, were also similar to those found in the intes-
tinal microbiome, although between 24 and 31% of the
sequences were annotated as “unknown function.” The
search for activities related to the metabolism of choles-
terol and bile salts in the MetaCyc metabolic pathway
database showed differences between the three samples.
As shown in Table 3, a clear difference was observed for
the superpathway of cholesterol biosynthesis and to a
minor extent glycocholate metabolism, with 2 to 4 times
more genes related with this pathway in samples H-04
and H-05, respectively, as compared to H-06. Additionally,
when comparing with similar activities against metagen-
omes from fecal samples of five healthy individuals
(see the “Methods” section for accession numbers and
reference), differences were observed for cholesterol
oxidase genes, more abundant in bile. On the contrary,
bacterial genes for glycocholate metabolism were more
abundant in the fecal datasets.
Bile microbiota load and compositional profiles:
comparison between lithiasis and non-lithiasis
To compare the human gallbladder microbiota in individ-
uals with no diagnosed hepatobiliary diseases vs a disease
state, bile samples were obtained during surgery from pa-
tients (n = 14) diagnosed with cholelithiasis. The bacterial
load was determined by qPCR, as for the control group
(n = 13), and the results are shown in Fig. 3. No statistical
differences were observed between either group for the
total number of bacterial cells (Mann-Whitney U test,
p value < 0.05), but much more variation (reaching
levels of 104–106 in some cases) was found in the bile
of patients with gallstones.
Bile microbial composition was determined by high-
throughput sequencing by paired-end Illumina technol-
ogy of 16S rRNA gene amplicons. In order to evaluate
the potential DNA contamination associated to low bac-
terial biomass samples, three “blank” controls with no
template DNA (adding ultrapure molecular biology
grade water instead of bile for the DNA extraction
Fig. 1 Boxplots representing 16S rRNA gene and 18S rRNA gene levels in the control group (n = 13). The central rectangles represent interquartile
ranges (IQR), the lines inside the rectangles show the median, and the whiskers indicate the maximum and minimum values. The dots outside
the rectangles are suspected outliers (> 1.5 × IQR). Statistically significant differences (p value < 0.05) between the two variables (16S rRNA gene
and 18S rRNA gene) were found (Mann-Whitney U test)
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protocol) were also processed for sequencing. Bacterial
profiles and diversity from bile of both groups were
compared. On average, a total of 74,885 raw reads per
sample were obtained in the control group, and 100,510
in the cholelithiasis group. After quality and chimera fil-
tering, a mean of 63,473 and 41,997 high-quality partial
16S rRNA gene sequences were retrieved, respectively.
Sequences were classified, using QIIME and SILVA data-
base. In accordance with the shotgun metagenome re-
sults, the main phyla found in bile were Firmicutes,
Bacteroidetes, Actinobacteria, and Proteobacteria. Sig-
nificant differences in the relative abundance of different
taxa present in the bile of both groups were found after
the application of the Metastats statistical method with a
false discovery rate (FDR correction), adjusted following
the Benjamini-Hochberg method to 0.25. At phylum
level, Bacteroidetes was statistically less abundant in the
bile of control subjects (13.49% with respect to 24.00%
in cholelithiasis). Sequences belonging to the family
Propionibacteriaceae were more abundant in bile sam-
ples from the control group (mean relative abundance
10.77%) compared with samples from patients with
stones in the gallbladder (mean relative abundance
0.59%); meanwhile in patients, members of the families
Bacteroidaceae, Prevotellaceae, Porphyromonadaceae, and
Veillonellaceae were more frequently detected (10.21%,
3.23%, 2.36%, and 1.78%, respectively) (Table 4). Classifica-
tion was assigned to the genus level when possible; other-
wise, the closest taxonomic rank was given, preceded by
unknown member “U. m.” (Table 5). In cholelithiasis pa-
tients, within the Bacteroidaceae family, Bacteroides was
the genus that showed a significantly higher proportion,
as compared with the control group (mean 10.21% vs
2.74% of relative abundance, respectively, p value = 0.001).
Within the family Veillonellaceae, the genus Dialister also
showed a significantly higher representation in the group
of patients with gallstones. Moreover, a significantly higher
percentage of assigned reads to the enterobacteria
Escherichia-Shigella was observed in the bile of these
patients. However, sequences assigned to other genera
from the Alpha (Bradyrhizobium, Methylobacterium, and
Sphingomonas) and Gamma (Acidibacter and Brevundi-
monas) divisions of the Proteobacteria phylum were more
abundant in the control group. In contrast, no amplifica-
tion was observed from any of the three blank controls in-
cluded in this study. In this regard, to further support the
existence of an autochthonous biliary microbiota, different
cultivation techniques were used. We were able to identify
several isolates from a selection of bile samples, and in all
cases, the microbial profile determined by 16S rRNA gene
sequencing contained sequences (at genus or family level)
that matched with the corresponding isolates of each sam-
ple (data not shown)
The OTU-based microbial diversity was estimated.
The intra-subject alpha diversity was estimated on data
rarefied to the sequencing depth obtained in the sample
with the lowest number of sequences (i.e., 20,000). The
Shannon index (H) was determined for each sample.
The median of this diversity index was statistically
higher in the bile of the control group than that ob-
tained in the patients with gallstones (Mann-Whitney U
test, p value = 0.038) (Fig. 4). On the other hand, after
applying Principal Coordinate Analysis (PCoA) to the
weighted UniFrac distance matrix generated from the
comparison between the microbiota identified in bile
samples of cholelithiasis patients vs non-cholelithiasis
(control group), we noticed that the non-cholelithiasis
bile samples grouped together showing more similarities
to each other, than to those samples from the cholelithia-
sis patients (Fig. 5). When analysis of molecular variance
(AMOVA) was used to assess the statistical significance of
the spatial separation observed, significant differences in
Table 2 Percentages (%) of quality and human filtered reads
assigned at the ranks of superkingdom and phylum from three
control bile samples subjected to shotgun metagenomics
Taxonomic assignment Sample code
Superkingdom Phyluma H-04 H-05 H-06
Not assigned 32.67 20.96 33.13
Archaea 0.02 0.06 0.04
Eukaryota 2.11 0.21 1.83
Viruses 0.12 5.58 0.20
Bacteria 65.08 73.19 64.79
Actinobacteria 13.17 2.91 12.23
Bacteroidetes 34.36 34.22 35.60
Firmicutes 22.47 56.51 23.10
Proteobacteria 27.80 5.46 27.06
Verrucomicrobia 0.16 0.43 0.25
Chlamydiae 0.73 0.01 0.55
Acidobacteria 0.18 0.04 0.14
Planctomycetes 0.20 0.05 0.20
Spirochaetes 0.14 0.07 0.12
Fusobacteria 0.09 0.05 0.10
Tenericutes 0.05 0.08 0.09
Deinococus-Thermus 0.02 0.00 0.01
Fibrobacteres 0.00 0.00 0.02
Synergistetes 0.00 0.02 0.00
Cyanobacteria 0.11 0.03 0.08
Chloroflexi 0.03 0.01 0.03
Chlorobi 0.00 0.00 0.02
Nitrospirae 0.00 0.00 0.01
Unclassified bacteria 0.49 0.21 0.38
aAbundances of different phyla are related to total assigned
bacteria sequences
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Fig. 2 Distribution of Clusters of Orthologous Groups (COGs) in three bile samples from control group (H-04, H-05, and H-06). The results show
the percentage of sequences assigned to different metabolic functions (relative to all sequenced microbes). Secondary metabolite biosynthesis
includes antibiotics, pigments, and non-ribosomal peptides. Inorganic ion transport and metabolism includes phosphate, sulfate, and various
cation transporters
Table 3 Microbial functional genes related to the metabolism of cholesterol and BA assigned (ratio 1/10,000 reads) through
MetaCyc metabolic pathway database in three metagenomes from human bile and five fecal metagenomes from healthy subjects
from a previous study [20]
Bile samples Fecal samples Average
bile
Average
gutPathway H-04 H-05 H-06 2HS 26HS 30HS 31HS 32HS
Cholesterol biosynthesis I 0.13 0.02 0.29 0.00 0.00 0.00 0.08 0.00 0.15 ± 0.11 0.02 ± 0.03
Cholesterol biosynthesis II
(via 24,25-dihydrolanosterol)
0.13 0.02 0.29 0.00 0.00 0.00 0.08 0.00 0.15 ± 0.11 0.02 ± 0.03
Cholesterol biosynthesis III
(via desmosterol)
0.13 0.02 0.29 0.00 0.00 0.00 0.08 0.00 0.15 ± 0.11 0.02 ± 0.03
Superpathway of cholesterol
biosynthesis
0.37 3.29 15.31 0.12 0.21 0.25 1.06 0.25 6.32 ± 6.47 0.38 ± 0.34
Superpathway of cholesterol
degradation I (cholesterol
oxidase)
1.06 0.17 0.21 0.41 0.46 0.39 0.48 0.71 0.48 ± 0.41 0.49 ± 0.11
Superpathway of cholesterol
degradation II (cholesterol
dehydrogenase)
1.52 0.34 0.36 0.54 0.5 0.47 0.62 0.81 0.74 ± 0.55 0.59 ± 0.12
Cholesterol degradation to
androstenedione I
(cholesterol oxidase)
0.35 0.02 0.07 0.00 0 0.00 0.01 0.02 0.15 ± 0.15 0.01 ± 0.01
Cholesterol degradation to
androstenedione II
(cholesterol dehydrogenase)
0.74 0.05 0.21 0.00 0.00 0.00 0.06 0.02 0.33 ± 0.29 0.02 ± 0.02
Bile acid biosynthesis, neutral
pathway
0.61 0.07 0.29 0.06 0.06 0.02 0.11 0.05 0.32 ± 0.22 0.06 ± 0.03
Glycocholate metabolism
(bacteria)
1.58 2.71 0.72 10.58 15.03 12.4 15.53 12.35 1.67 ± 0.81 13.18 ± 1.84
Cholate degradation
(bacteria, anaerobic)
0.35 0.46 0.14 0.97 0.77 0.41 0.62 0.38 0.32 ± 0.13 0.63 ± 0.22
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the microbial clustering between both groups were re-
vealed (p value < 0.001).
Bile metabolomics
Neither the pH values nor the UV/visible spectra
showed statistical differences between bile samples of
both groups (data not shown). A pH mean value of
7.51 ± 0.88 was obtained for the bile samples. In relation to
the absorbance spectra, two samples from the cholelithiasis
group (C-09 and C-10) showed a blood-stained aspect,
showing a maximum in 415 nm. This was not observed in
any of the bile samples from the control group.
The assignment of the signals from 1H-NMR spectrum
is depicted in Table 6. Signals from glycine/taurine-con-
jugated BA, phosphatidylcholine, unspecific methylene
groups from glycerides, cholesterol, and primary BA
characterized the spectra of the samples of gallbladder
bile. Considering the signals of the whole spectra, a sta-
tistically significant separation between bile samples of
the two groups was detected (p value < 0.05) by principal
component analysis (PCA) (Fig. 6). Besides, the split of
the spectrum in two sections (0.15–4.20, aliphatic;
5.00–10.00, aromatic) led to a significant discrimination
of the samples depending on types of individuals (patients
vs controls). Therefore, the differences in the aliphatic sec-
tion could be related to the content of chenodeoxycholic
(CDCA), deoxycholic acid (DCA), and cholic acids (CA),
whereas the differences within the aromatic section would
be caused by their glycine- and/or taurine-conjugated
forms. The highest percentage of explained variance was
obtained by considering the whole spectrum, thus explain-
ing a total of 76.23% in a plot of PC1 (63.06 %) vs PC2
(13.17 %). PCA results evidenced that the second principal
component was closely related to bile sample type
(controls “H” vs cholelithiasis “C”). It was observed that
the control samples showed positive values for PC2,
whereas those from patients with cholelithiasis presented
negative values (Fig. 6).
Discussion
The advent and refinement of novel sequencing method-
ologies during the 21st century, the so called next-
generation sequencing (NGS) methods, together with
bioinformatics-based analyses, have revolutionized how
we study the human microbiome. Thanks to these tech-
niques, we are able to extract the information encrypted
in the genomes of the intestinal microbiota members, as
well as to depict the diversity and potential metabolic
capabilities of this microbial community. The human
fecal microbiota has largely been studied, and numerous
links have been established between these microbial
communities and different physiological conditions, a
Fig. 3 Boxplots representing 16S rRNA gene levels between cholelithiasis (n = 14) and control group (n = 13). The central rectangles represent
interquartile ranges (IQR), the lines inside the rectangles show the median, and the whiskers indicate the maximum and minimum values. The
dots outside the rectangles are suspected outliers (> 1.5 × IQR). Statistically significant differences (p value < 0.05) between the two groups of the
study were not found (Mann-Whitney U test)
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process that has been favored, at least in part, due to the
ease of obtaining non-invasive biological samples. The
characterization of other human microbial niches has
been hampered by difficulties in accessing solid biopsies
or liquid fluids and the lack of adequate methodologies
to assess molecular studies in microbial ecosystems with
a low bacterial load. Within these “other microbiotas,”
recent evidence suggests that a variety of internal bio-
logical fluids possess a native microbiota, among which
human milk and blood have received particular attention
[7, 8, 21, 22]. However, caution should be taken for the
presence of contaminating DNA when applying
sequence-based techniques to the study of the micro-
biome in low biomass environments [23]. In our study,
we analyzed the microbial load of human bile by qPCR.
Remarkably, our quantitative results might be underesti-
mated as we observed that, after enrichment of bile
samples with different amounts of L. lactis cells, the
bacterial cells quantified by 16S rRNA gene analysis
were usually lower than the total number of cells
added to the bile sample, suggesting that the primer
choice or the cell lysis method could influence quan-
titative estimations.
To date, the microbiota of the human gallbladder has
scarcely been studied, and current results are limited to
a few hepatobiliary pathological conditions in which the
gallbladder has been resected during surgery. Cultivation
and culture-independent techniques have shown that
enterobacteria are frequently isolated and detected in
cholecystitis and cholelithiasis samples, although the
lack of optimal culture conditions suitable for other mi-
croorganisms could allow those adapted to the biliary
niche to pass unnoticed [11–13]. Remarkably, besides
some fecal bacterial indicators of cholelithiasis, such as
the genera Roseburia and Oscillospora [24], one of the
few bacteria frequently associated with the presence of
Table 4 Differences in microbial relative abundance (% of sequences) in bile at family level between cholelithiasis patients and the
control group. Only families with a mean relative abundance higher than 0.5% are presented. Only families that were detected in
more than half of the samples in each group were considered for the analysis
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gallstones is Salmonella enterica, which is able to
colonize and persist in the human gallbladder [25]. Only
recently, using massive sequencing techniques, a few re-
ports analyzed the biliary microbiome of the human gall-
bladder potentially associated with the generation of
gallstones; however, the relatively low number of se-
quences analyzed and the absence of gallbladder control
samples (samples from individuals without hepatobiliary
pathology) hampered the yield of physiologically relevant
results and made challenging to establish a microbiota
profile associated with cholelithiasis. Among these studies,
the analysis of a group of 29 Chinese patients with gall-
bladder gallstones showed that the biliary core micro-
biome was constituted by 6 phyla: Actinobacteria,
Bacteroidetes, Firmicutes, and Proteobacteria being the
predominating phyla, and Bacteroides the most abundant
Table 5 Differences in microbial relative abundance (% of sequences) in bile at genus level between cholelithiasis patients and the
control group. Only genera with a mean relative abundance higher than 0.5% are presented. Only genera that were detected in
more than half of the samples in each group were considered for the analysis
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genus [17]. Similar results were found by Saltykova and
co-workers, who observed that these four phyla domi-
nated the human gallbladder microbiota of patients with
gallbladder gallstones [18]. Our results also point to the
predominance of these four phyla in bile obtained from
the gallbladders of cholelithiasis patients, all of them with
gallbladder gallstones, and the highest number of se-
quences assigned to a specific genus was for Bacteroides
(Table 5). On the other hand, a few works have analyzed
the human microbiota of samples from the common bile
duct, using endoscopic retrograde cholangiopancreatogra-
phy (ERCP) for sample collection, obtained from patients
with gallstones in the common bile duct [14–16]. Overall,
these studies showed a high abundance of the phyla Firmi-
cutes, Bacteroidetes, and Proteobacteria, with a lower rep-
resentation of Actinobacteria and other phyla.
Fig. 4 Comparison of Shannon’s diversity indices in cholelithiasis (n = 14) and control (n = 13) groups. The central rectangles represent
interquartile ranges (IQR), the lines inside the rectangles show the median, and the whiskers indicate the maximum and minimum values.
The dots outside the rectangles are suspected outliers (> 1.5 × IQR). Statistically significant differences (p value < 0.05) between groups
were found (Mann-Whitney U test)
Fig. 5 Principal Coordinate Analysis (PCoA) plot of weighted UniFrac distances, comparing the bacterial communities among samples from
cholelithiasis (red circles, n = 14) and control group (blue circles, n = 13). Percentages shown in the axes represent the proportion of dissimilarities.
Analysis of molecular variance (AMOVA) was used to assess the statistical significance of the spatial separation between both groups
(p value < 0.001)
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Until now, the microbial populations inhabiting the
human gallbladder in individuals without any hepatobili-
ary disorder had not been studied. Our group has re-
cently shown that healthy pigs have a native microbiota
[19], and this led us to think that humans, even in the
absence of pathologies, can also hold a native gallbladder
microbiota. Thus, in our study, we have tried to take an-
other step in the characterization of the human bile
microbiome, and in order to compare the microbial pro-
file of cholelithiasis patient’s vs a non-pathological con-
dition, we have established a control or reference group
with samples from individuals without any hepatobiliary
disease. Given the difficulty of obtaining bile samples
from healthy individuals due to obvious ethical reasons,
we have tried to overcome the problem to obtain sam-
ples from a “healthy group” by collecting samples from
liver donors without any record of biliary or hepatic dis-
orders. Since antibiotic prophylaxis is a standard proto-
col for liver transplantation, with the aim of minimizing
the potential effect of antibiotics on the biliary micro-
biota, we only selected samples from liver donors that
had received antibiotics at the intensive care unit (ICU)
for less than 24 h before the surgery. Even so, we are
aware that this antibiotic treatment (see the “Methods”
section for details) may constitute a limitation of our
study and could affect the endogenous microbiota of
bile. Regrettably, as commented above, this was due to
the difficulty in obtaining bile samples from healthy vol-
unteers. In the bile samples of this control group, we
found sequences matching some genera of the Alpha
division of Proteobacteria (Bradyrhizobium, Methylobac-
terium, and Sphingomonas) that were previously associ-
ated with nitrogen fixation and potential contaminants
of ultrapure water systems [26]. In this regard, with our
template-free “blanks” (in which the bile sample had
been substituted by molecular biology grade water in the
DNA extraction procedure), no amplification from the
16S rRNA gene was achieved, suggesting an extremely
low bacterial load in the water, and sequencing results
could not be obtained. Therefore, we were not able to
confirm if these genera (representing around 10% of
total assigned reads) constitute a potential contamin-
ation or background signals, a fact that is plausible in
high-throughput sequencing approaches using biological
specimens with low bacterial load, as is the case of our
control bile samples (Fig. 3). Therefore, we cannot com-
pletely rule out the possibility of introducing a minor
bias in our sequence-based microbiome study of bile
control samples from liver donors, but shotgun metage-
nomic analyses corroborated the data of 16S rRNA gene
profiling, indicating the existence of three main phyla
(Actinobacteria, Bacteroidetes, Firmicutes) apart from
Proteobacteria (Table 2) in human bile samples, which is
in accordance with previous literature of this environ-
ment [17, 18]. In addition, from the liver donors, we ex-
tracted DNA from gallbladder tissues removed during
liver transplantation surgery. 16S rRNA gene profiling
was carried out in three of these biopsies (from individ-
uals H-04, H-05, and H-06), revealing the presence of a
low abundance of bacterial amplicons, mainly belonging
to Firmicutes, Bacteroidetes, and Actinobacteria phyla.
Observed eukaryotic amplicons ranged between 75 and
85% of the total profile. Based on our previous experi-
ence, such results indicate that the vast majority of the
retrieved DNA is eukaryotic (data not shown).
Furthermore, weighted PCoA analysis grouped the bil-
iary microbiota of the two study groups (non-lithiasis vs
lithiasis patients) differently, showing a higher dispersion
Table 6 Signal assignments for 1H-NMR spectra obtained from
gallbladder bile
Chemical shift Compounds
0.00 TSP (internal standard)
0.67 BA (H18)
0.71 Cholesterol (H18)
1.42 Lipids (CH2)n
1.49 BA cholesterol + lipids
2.38 BA cholesterol + lipids
2.74 Lipids
2.78 Lipids
2.81 Lipids
3.07 Conjugated taurine
3.24 Phosphatidylcholine
3.49 CA+CDCA
3.56 DCA + conjugated taurine
3.63 Phosphatidylcholine
3.74 Conjugated glycine
3.84 CA+DCA
3.88 CA, CDA, + PC-glycerol
4.28 PC-glycerol
4.31 Phosphatidylcholine
4.44 PC-glycerol
4.46 PC-glycerol
4.83 Residual water
5.32 Lipids, cholesterol PC-glycerol
7.83 Glycochenodeoxycholic acid
7.86 Glycodeoxycholic acid
7.88 Glycocholic acid
7.99 Taurochenodeoxycholic acid
8.00 Taurodeoxycholic acid
8.01 Taurocholic acid
BA bile acids, CA cholic acid (primary), CDCA chenodeoxycholic acid (primary),
DCA deoxycholic acid (secondary), TSP 3-(trimethylsilyl) propionicacid-d4,
PC-glycerol phosphatidylcholine-glycerol
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among the samples from cholelithiasis patients. Statis-
tical differences in the microbial relative abundances
of sequences between both groups, at family and
genus level, were also noticeable. Within the different
genera detected, the highest statistical significance
was observed for Bacteroides and Escherichia-Shigella
(more abundant in the cholelithiasis patients) and
Sphingomonas (more abundant in the control group).
As previously mentioned, enterobacteria are frequent
in the bile of cholelithiasis patients [11–13].
Furthermore, it is worth highlighting that half of the
cholelithiasis patients have altered levels of total chol-
esterol or triglycerides at the time of sampling, or a
clinical history of hypercholesterolemia and/or obesity
(Table 1 and Additional file 1: Table S1). In this re-
gard, high abundance percentages of Bacteroides in
the fecal microbiota have been linked to the con-
sumption of a diet rich in animal fat [27, 28]. In ac-
cordance with our microbiological and metabolic
results found in bile from patients with cholelithiasis,
it has been previously reported that high-fat intake
increases BA secretion, and accordingly, animal-based
diets increase the abundance of bile-tolerant microor-
ganisms in the gut, such as Bacteroides [28]. Al-
though results on human intestinal microbiota cannot
be directly compared with the biliary microbiota de-
scribed in our work, we hypothesized that diet rich in
saturated fat and cholesterol levels, two factors that
have been related to the appearance of cholelithiasis
[29], might favor microorganisms, such as Bacteroides,
in the biliary micro-environment.
From the 16S rRNA gene profile analysis, it seems that
3 to 4 phyla constitute the core population of human
bile, and relevant differences at family and genera level
are highlighted depending on the specific physiological
condition of the host.
After a careful selection of samples from the control
group, only three of them with a reasonably high 16S/
18S ratio were used for shotgun metagenomic analysis.
We have seen that the distribution of the main func-
tional categories in the biliary metagenome is similar to
that described in the human gut microbiota [30]. How-
ever, it is worth highlighting that genes related to the
metabolism of cholesterol and BA biosynthesis are
present at higher relative abundance in the human bile
microbiome with respect to that of the human gut [20].
This could reflect the adaptation of the bile microorgan-
isms to this specific niche. However, the interpretation
of these results should be taken with caution, due to the
small number of samples analyzed from the control
group (3 individuals) and to the particular physiological
conditions of the liver donors (a period of stay in the
hospital’s ICU and the unavoidable standard-of-care
antibiotic treatment), considering that the comparison of
gallbladder and fecal microbiotas was not carried out
within the same group of individuals (liver donors who
had suffered a brain accident or stroke vs healthy
individuals).
Fig. 6 Principal component analysis (PCA) plot of bile metabolites. PC1 versus PC2 obtained for the whole spectra is represented. Control samples are
represented in black. Blue dots belong to bile samples from cholelithiasis patients
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Regarding the biochemical analysis of the bile samples,
the pH values of the samples were within the range pre-
viously described in bile from gallbladders [31]. Attend-
ing to the color analysis, the maximum at 415 nm of two
samples coming from patients with cholelithiasis could
be associated to hemoglobin [32]. Together, the differ-
ences in shapes of the spectra of the rest of samples, al-
though not statistically significant, could be related to
the heterogeneity on the concentration of pigments (bili-
rubin and biliverdin) and bile salts, the aggregation state,
and the oscillations of pH values [33, 34].
With respect to the metabolic NMR profiles (Table 6),
high levels of the secondary BA deoxycholic acid (DCA)
in blood and feces have been associated with increased
risk of cholesterol gallstone disease [35]. Statistically sig-
nificant differences between bile samples from controls
and patients were found when considering the com-
pounds of both the aromatic and the aliphatic regions of
the spectra (Fig. 6). In agreement with this, several au-
thors have stated that different levels of BA or its glycine
and/or taurine conjugates play an important role in cho-
lestasis [36, 37]. Besides, Ijare and colleagues described a
major role of the amide proton region of the 1H-NMR
spectra of human bile in differentiating cholestatic pat-
terns from normal ones [38]. Further studies are
mandatory to characterize in depth the potential rela-
tionships between the biliary metabolic and microbial
profiles.
Conclusions
This work is the first study pointing to the existence of a
human gallbladder microbiota in individuals without any
hepatobiliary disease and establishing a link between bile
microbiota and pathological conditions. The 16S rRNA
gene profiling and the metagenomic analysis allowed us to
propose the existence of a microbial bile ecosystem and to
access the main taxonomic and functional profiles present
in this microbiome. Furthermore, the metabolomics ana-
lysis showed that the two study groups have different
metabolic profiles. We are aware of the moderate sample
size of our work, mainly related to the number of liver
transplants carried out in the collaborating hospitals dur-
ing the one and a half year sampling period and to the
strict inclusion criteria for the two study groups. Also, the
difficulty of obtaining gallbladder samples from healthy
volunteers and the inherent disadvantage of working with
biological samples with a low bacterial load must be taken
into account. In addition, we must bear in mind that the
results of the control group have been obtained with liver
donors that have been subjected to the specific protocols
of the hospital’s ICU, including an unavoidable standard-
of-care short antibiotic treatment that could introduce a
bias in the physiologically normal biliary microbiota. Even
considering these limitations, our results establish the
basis for future larger-scale studies on the relationship be-
tween bile microbiota, gut microbiota, human metabol-
ism, and health. Future investigations should be oriented
to unraveling the role and influence of the biliary micro-
biota in the pathophysiology of this (lithiasis) and other
human diseases related to diet, bile, and cholesterol me-
tabolism. These findings might open promising strategies
to search for novel biomarkers associated with the disease
or dietary strategies that could help prevention and/or pa-
tient care and treatment.
Methods
Bile samples and patients
Human bile samples from the gallbladders of individuals
without hepatobiliary disease were obtained during liver
transplants from liver donors who had suffered a brain
accident or stroke (control group or reference group; H-
sample codes). Although a total of 26 donors were ini-
tially recruited and sampled, a further selection of bile
samples for the microbiological study was applied in
order to have a homogenous reference group. The cri-
teria used for selection were as follows: less than 80
years old, no more than a 48-h stay in the hospital’s ICU
before the transplant, and had not received antibiotics at
ICU for more than 24 h. In all selected cases, the anti-
microbial treatment consisted on 2 g of amoxicillin-
clavulanic acid every 6 h until liver transplantation sur-
gery. Other characteristics of this selected control group
(n = 13) were as follows: 4 male and 9 female and aged
range 37 to 79 years old. The samples of bile from the
gallbladders were collected aseptically during the surgery
by physicians at the General Surgery Service of HUCA
(Central University Hospital of Asturias, Spain). The sur-
geons also confirmed the absence of gallstones and
sludge from the donors.
Bile samples from gallbladders from a similar group in
gender and age (3 male and 11 female, age range 27 to
73 years old), with a bile disorder (diagnosed with chole-
lithiasis), were obtained from 14 patients (n = 14) with
gallstones, who underwent surgical gallbladder removal
at Cabueñes Gijon University Hospital (Asturias, Spain)
(Cholelithiasis group; C-sample codes). General charac-
teristics and clinical parameters of the patients are re-
ported in Table 1. None of the patients received
previous antibiotic prophylaxis (which was considered as
an exclusion criterion), and the intervention was per-
formed in all of them by laparoscopic cholecystectomy.
The recruitment of patients was undertaken by physi-
cians of the General and Digestive Surgery Service of
Cabueñes Gijon University Hospital, Spain. After bile
collection, bile samples were immediately transported
refrigerated to the laboratory and stored at − 80 °C until
use. Comparison between clinical parameters of both
groups of individuals (patients with cholelithiasis and
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liver donors as controls), from whom bile samples were
obtained in this study, is reported in Additional file 1:
Table S1. Additionally, there were no statistical differ-
ences with respect to gender (79% female and 21% male
in patients with cholelithiasis vs 69% female and 31%
male in controls) and age (52 years old in patients vs 59
in controls) between both groups.
Ethical approval for this study was obtained from the
Bioethics Committee of CSIC (Consejo Superior de
Investigaciones Científicas) and from the Regional Ethics
Committee for Clinical Research (Servicio de Salud del
Principado de Asturias n°112/13) in compliance with the
Declaration of Helsinki of 1964. All experiments were
carried out in accordance with the approved guidelines
and regulations.
Microbial analysis of bile samples
DNA extraction and quantification
Total DNA extraction from 1-ml bile samples was per-
formed following an optimized protocol based on a pre-
viously described method [19], with slight modifications.
Briefly, samples were centrifuged at maximum speed at
room temperature for 10 min and pellets re-suspended
in 0.5 ml of extraction buffer consisting of 200 mM Tris-
HCl pH 7.0, 25 mM EDTA, 250 mM NaCl, and the fol-
lowing enzymes: 20 mg/ml lysozyme (Merck, Darmstadt,
Germany), 5 μg/ml of lysostaphin (Sigma-Aldrich, Saint
Louis, MO, USA), and 40 U/ml mutanolysin (Sigma-Al-
drich). Enzymatic lysis was performed for 1 h at 37 °C;
after that, SDS was added to a final concentration of
0.5% (w/v), and mechanical disruption was performed in
a FastPrep FP120 apparatus (Qbiogene, Carlsbad, CA,
USA). The lysate solution was treated with proteinase K,
1.5M NaCl as previously described [39] and extracted
with phenol/chloroform. Precipitation of DNA was per-
formed with 0.1 volumes of 3M sodium acetate pH 5.2
and 2.5 volumes of cold ethanol. The DNA was then
pelleted, washed with 70% ethanol, resuspended in 50 μl
of molecular-biology grade water (Sigma-Aldrich), and
stored at − 20 °C until use. DNA concentration and qual-
ity was determined in a BioTek Epoch™ spectrophotom-
eter system (Thermo Fisher Scientific, Inc., Waltham,
MA, USA) and in parallel in a Qubit fluorometer with
dsDNA assay kits (Thermo Fisher Scientific).
Determination of prokaryotic and eukaryotic DNA by qPCR
Differentiation and quantification of eukaryotic and pro-
karyotic DNA from bile samples were carried out by
qPCR using specific primers targeting the 18S rRNA
gene of eukaryotic cells [40] and the 16S rRNA gene of
prokaryotic microorganisms [41]. Amplification reac-
tions were performed in 96-well optical plates (Applied
Biosystems, Foster City, CA, USA) in a 7500 Fast Real-
Time PCR System (Applied Biosystems). Amplifications
were done in triplicate in a final volume of 25 μl con-
taining 2× SYBR Green PCR Master Mix (Applied Bio-
systems), 0.2 μM of each primer, and 1 μl of DNA
obtained from bile. Primer efficiency was calculated
from the slope of the standard curve (E = 10−1/slope).
Standard curves were generated by plotting the Ct values
against the numbers of cells corresponding to serial ten-
fold dilutions of cultures of L. lactis strain NZ9000 as a
reference for prokaryotic DNA and calculated by plate
counting [42] and HT-29 cell line as a reference for
eukaryotic DNA and titrated under an inverted micro-
scope with a Neubauer Chamber [43]. To simulate dif-
ferent bacterial loads in the bile matrix, human bile was
artificially supplemented with serial tenfold dilutions of
known concentrations (ranged from 102 to 107 cfu/ml)
of a grown culture of L. lactis strain NZ9000.
Shotgun metagenomic sequencing and analysis
Extracted DNA of three bile samples from the control
group were used for total shotgun sequencing. DNA was
fragmented to 550–650 bp using a BioRuptor machine
(Diagenodo, Belgium) and subsequently prepared with
the Next era XT Library Preparation kit (Illumina, San
Diego, CA, USA). Sequencing was performed at the
DNA sequencing facility of GenProbio SRL (Parma,
Italy) using an Illumina MiSeq System with MiSeq Re-
agent Kit v3 chemicals (Illumina).
The fastq files were filtered for reads with quality < 25
and presence of alien DNA, as well as for reads < 150
bp. Bases were also removed from the end of the reads
until the average quality in a window of 5 bp was > 25.
Only paired data was further analyzed. Assembly of the
shotgun dataset and annotation of the reads was per-
formed with the MEGAnnotator platform [44]. Taxo-
nomic classification was obtained using a combination
of RapSearch2 software [45] and the non-redundant
NCBI database (BLASTx), and MEGAN5, in order to re-
construct taxonomic profiles based on reads covering
coding regions. Functional analysis of the reads was
achieved using CAZy [46], EggNOG [47], and MetaCyc
[48] databases. Specifically, COG functional class profil-
ing was based on the EggNOG database; meanwhile,
metabolic pathway prediction was based on the MetaCyc
database. Abundance of genes related to the metabolism
of cholesterol and BA was compared with those found
in fecal metagenomes of five healthy individuals used as
controls in a previous study [20]. These dataset se-
quences are available at the Sequence Read Archive
(SRA) database under the accession number SRP125191.
High-throughput sequencing and analysis of 16S rRNA gene
amplicons
Partial 16S rRNA gene sequences were amplified from
the extracted DNA of 27 bile samples (13 controls and
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14 patients) using the primer’s pair Probio_Uni and
/Probio_Rev, which target the variable region V3 of the
bacterial 16S rRNA gene, as previously described [49].
Samples were submitted to 2 × 250 bp paired-end se-
quencing by means of an Illumina MiSeq System (Illu-
mina). Sequence reads were filtered by the Illumina
software to remove low-quality sequences. All Illumina
quality-approved, trimmed, and filtered sequences were
processed using a custom script based on the QIIME
software suite [50]. After joining the paired-end reads,
the quality control phase retained sequences with a
mean sequence quality score > 20 and a length between
140 and 400 bp. Sequences with homopolymer regions
> 7 bp and those with mismatched primers were omitted.
In order to calculate downstream diversity measures,
16S rRNA Operational Taxonomic Units (OTUs) were
defined at 100% sequence homology using DADA [51];
OTUs not encompassing at least 2 sequences of the
same sample were removed. All sequences were classi-
fied to the lowest possible taxonomic rank using QIIME
and the SILVA database as reference [50, 52]. Similarity
of the bacterial communities between samples was cal-
culated by weighted UniFrac method [53]. All raw data
was deposited in the SRA of the NCBI (https://www.
ncbi.nlm.nih.gov/sra) under accession numbers
SRR6872870 to SRR6872896 (for the 16S rRNA gene se-
quencing data) and SRR6877525 to SRR6877527 (for the
shotgun sequencing data).
Metabolic analysis of bile samples
pH and color determination
pH and UV-visible spectra were measured on each of
the collected bile samples. A CRISON GLP21 pH-meter
was used to the pH measurement. Optical density was
measured between 200 and 800 nm in a spectrophotom-
eter Zenyth 200RT (Anthos Labtec Instruments GmbH,
Salzburg, Austria).
Sample preparation for NMR analysis of metabolites
The same samples used for the microbiota analysis were
used for the NMR analysis, excluding sample C-14 (this
sample was not available after the 16S rRNA gene profil-
ing and the optimization of analyses protocols). The in-
tact bile samples were frozen at − 80 °C, freeze-dried,
and stored under vacuum at − 80 °C. For NMR analyses,
5 mg of bile and 50 μl of a 1 mM solution in distilled
water of the sodium salt of the 3-(trimethylsilyl)
propionicacid-d4 (TSP) were mixed with 550 μl of dis-
tilled water, and the mix was transferred to 5-mm diam-
eter NMR glass tubes. TSP was added to provide an
internal reference standard and a field-frequency lock
(0.00 ppm).
1D 1H-NMR experiments
NMR experiments were performed on a Bruker Biospin
Avance 700-MHz NMR spectrometer. Spectra were re-
corded using the following pulse sequences: 1D NOESY
(NOESYPRESAT) and CPMG (Carr Purcell Meiboom
Gill), both with water suppression. The 1D NMR experi-
ments were acquired with 32k time domain data points,
18 ppm spectral width, 64 scans, and 2 s of relaxation
delay. A mixing time of 150 ms was used in the 1D
NOESY experiment and an echo time of 50 ms was se-
lected for the CPMG sequence. The free induction de-
cays (FIDs) obtained were processed with Bruker
BioSpin TOPSPIN software (version 3.1) as follows: ex-
ponential filtering (LB ¼ 1 Hz), Fourier transformation
(FT), spectral phasing, and baseline correction.
2D 1H-NMR experiments
Assignments of NMR signals were based on standard
two dimensional experiments, namely, 1H-1H COSY,
1H-1H TOCSY, 1H-13C HSQC, and 1H-13C HMBC.
Homonuclear water suppressed COSY and TOCSY
experiments were performed with 2k data points in t2
domain and 384 increments in t1, each with 64 scans.
Spectral widths of 13 ppm were employed in both di-
mensions. Mixing times of 70 ms were used for
TOCSY experiments. Heteronuclear HSQC and
HMBC experiments of these liquid samples were per-
formed as follows: 2k data points in t2 domain and
384 increments in t1, each with 256 scans; spectral
widths of 13 ppm for f2 dimension and 260 ppm for f1
dimension; coupling constant values of 145 Hz and
10 Hz were employed to set delay durations for short
range and long range correlations, respectively. In all
cases, two-dimensional data sets were enhanced in
the first dimension by forward linear prediction from
384 to 512 real data points followed by zero filling to
1024 data points. In addition, squared sine bell win-
dow functions were applied in both dimensions prior
to Fourier transformation. Assignment of resonances
in the 1H-NMR spectra was based on both spin con-
nectivity information obtained from 2D experiments
and the use, as guidelines, of both data reported in
the literature [36] and data obtained from HMDB
database (Human Metabolite Data Base http://www.
hmdb.ca/).
Statistical analyses
The identification of differentially abundant taxa was
assessed using the Metastats program [54]. Multiple hy-
pothesis tests were adjusted using the false discovery
rate (FDR) correction; an FDR threshold of 0.25 was
used to identify significant differences. Multivariable
statistical analysis of microbiological sequences was
performed by PCoA. Differences in the microbial
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distribution were sought by AMOVA. Comparisons
among other variables were performed by using the
non-parametric Mann-Whitney U test. A PCA was
developed on NMR signals as discrimination analysis.
Statistical analysis was performed using SPSS v. 22.00
(IBM, Armonk, NY, USA) and the free software R
(www.r-project.org).
Additional file
Additional file 1: Table S1. Data and clinical characteristics of both
groups of individuals (patients with cholelithiasis and liver donors as
controls) from whom bile samples were analyzed in this study. (DOCX 19 kb)
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